학술논문
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol
Document Type
Article
Author
Source
In: Trials . (Trials, December 2023, 24(1))
Subject
Language
English
ISSN
17456215